Introduction Emergency departments (EDs) are critical sites for hypertension (HTN) screening. Home blood pressure (BP) monitoring (HBPM) is used routinely in outpatient settings, yet its utility after the ED visit for those with elevated BP in the ED is unclear. Aim In this pilot study, we assessed if HBPM could detect HTN in patients with elevated in-ED BP. Methods From September 2014 to July 2017, we recruited adult patients at an urban, academic ED with a triage BP ≥ 120/80 mmHg and no history of HTN into this prospective cohort observational study. After their ED visit, participants obtained BP measurements for two weeks using a validated HBPM. HTN was considered probable if the average HBPM BP was ≥ 135/85 mmHg. We calculated the proportion of participants whose ED BP measurement accurately predicted HTN using HBPM after discharge. Results Of 136 participants enrolled, 93 (68%) returned the HBPM with at least four home BP measurements [mean number of measurements obtained: 29 (SD: 17, range 4-59)]. Participants' median age was 40 years-old (IQR 34-48); 55% were female, 19% were black, and 58% were white. Forty-six percent of participants with elevated in-ED BP had HTN in follow-up. Conclusions For patients with elevated BP in the ED, HBPM could be valuable for determining which patients have HTN and require expedient follow-up.
Introduction
Hypertension (HTN) is the leading modifiable risk factor for stroke and heart disease [1] . Emergency departments (EDs) commonly evaluate patients with elevated blood pressure (BP), with recent research showing that one fifth Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s4029 2-019-00300 -0) contains supplementary material, which is available to authorized users.
of ED visits are HTN-related [2] . Although EDs serve as a health care safety-net and could play an essential role in HTN screening and treatment, the validity of ED BPs and their potential predictive value for HTN is unknown. A common perception remains that HTN management and treatment should occur outside the ED [3] [4] [5] [6] . However, most ED patients with an elevated initial BP will continue to have elevated BPs after discharge, regardless of the severity of the presenting condition, pain or anxiety [7] .
ED visits for elevated BP are increasing [2] and rates of HTN awareness and control remain low in the United States [1] . As a result, in the past decade the Center for Medicare & Medicaid Services (CMS) [8] , the American College of Emergency Physicians [9] , and hypertension experts [10] [11] [12] have cited EDs as important sites for HTN screening and control. ED-based elevated BP management has been limited to performing evaluations for HTN-related end organ damage, and providing patient education and referral for further testing [13, 14] . However, recent advances and enthusiasm for digital health initiatives and technology-assisted self-management, have created new opportunities for patients to take an active role in disease diagnosis and management [15] . An example of these advances in the HTN realm include the increased adoption of home BP monitoring (HBPM) [16] .
HBPM is recognized as a helpful adjunct to officebased measurements for monitoring and diagnosing HTN, as well as the identification of white coat HTN [17] [18] [19] [20] . HBPM are a cost-effective and readily available alternative to ambulatory BP monitoring, can help titrate antihypertensive medication, promote patient engagement with care, and can expedite a diagnosis of HTN [21] [22] [23] . This is particularly important for ED patients who often cannot secure short-term follow-up for HTN [24] . Very little is known about using HBPM for patients after an ED visit in which they had elevated BP as a means to detect HTN after the ED visit [7] .
The objective of this pilot study was to evaluate using ED-provided HBPM to detect HTN after discharge and determine whether ED attending physicians could accurately predict HTN in their patients based on in-ED BP readings. Prior research shows that ED physicians provide little education to patients regarding the meaning of their elevated BP readings in the ED [25] , but this discussion is critical to motivate patients to make lifestyle modifications to decrease BP and seek follow-up for HTN after the ED visit. If ED physicians can accurately predict which of their patients will have HTN after the ED visit, then they could provide patients with valuable data on their cardiovascular risk and begin to motivate behavior change. We also tested the hypothesis that in-ED BPs could be used to predict HTN after discharge.
Methods

Study Design
This prospective observational cohort study was conducted between September 2014 and July 2017 among adult ED patients without a known diagnosis of HTN who had a triage BP ≥ 120 mmHg systolic and/or ≥ 80 mmHg diastolic. The hospital institutional review board approved this study.
Study Setting and Population
The study was conducted in New England at a level I, tertiary referral academic ED with an annual volume of over 110,000 adult patient visits. Patients had to be at least 18 years-old, speak English, and have a triage BP ≥ 120 mmHg systolic and/or ≥ 80 mmHg diastolic. Patients were ineligible if they had a known HTN diagnosis or were taking antihypertensive medication, receiving dialysis, pregnant, prisoners, intoxicated, admitted, or in infectious disease isolation. Additional exclusion criteria included having atrial fibrillation, chest pain, shortness of breath, unilateral weakness or numbness, altered mental status, an acute psychiatric problem, or using cocaine in the previous 30 days. We excluded patients with atrial fibrillation as HBPM may not provide an accurate BP for these patients. Patients with cocaine use may have elevated BP due to substance use rather than essential HTN. Patients who received any antihypertensive medication between the triage BP measurement and the BpTRU measurement were excluded. Patients who were unable to record at least four home BP measurement after ED discharge or who did not return their HBPM device were not included in the analyses. We based our study protocol on a previously published study that included ED patients [7] . According to this protocol, participants who were not able to obtain at least four BP measurements using the HBPM were excluded [7] .
Study Protocol
Research assistants (RAs) reviewed a random sample of the electronic health records of patients present in the ED during data collection periods. Prior to the study, the research staff created a randomized list of the study sites' ED treatment rooms. The RAs used this sequence to select which patient's record would be reviewed next for eligibility, reviewed those records for the triage BP and other criteria for study eligibility, and approached those who were potentially study eligible. Patients who met study criteria and provided consent could participate in the study. ED attendings caring for those participants also provided consent to be in the study.
Measurements
ED Visit Procedures
The triage BP was collected by nurses or certified nursing assistants at patient arrival using an automated BP device. No attempt was made by the study personnel to standardize or alter the collection of this measurement. The RA used the triage BP only as marker of study eligibility. After study enrollment, the RA obtained BP readings of each participant using the BpTRU device. The BpTRU device is considered the "gold standard" for office-based BP measurement as it has superior accuracy to other automated devices [26] . After patient consent, the RA checked the BP in both arms of the participant, and then obtained measurements from the arm with the higher BP measurement, as suggested in the BpTRU user manual [27] . After the initial BP measurement, the RA exited the room while the BpTRU device took five more readings at one-minute intervals. The RA's exit was intended to reduce "white coat" BP elevations. The BpTRU device omits the initial BP measurement and averages the latter five to produce a single measurement. Patients who did not have a BpTRU measurement of ≥ 120 mmHg systolic or ≥ 80 mmHg diastolic were excluded.
After ED Visit Procedures
After their ED visit, participants obtained their morning and evening BPs for two weeks using a validated HBPM device, the Omron BP760 [28, 29] . The HBPM stored up to 60 measurements obtained by participants. Participants also completed logs of their BP readings. The HBPM and participant-completed BP logs were returned to the research staff in pre-addressed postage-paid boxes or returned to the ED in-person.
Study Definition of HTN Using HBPM
For study purposes, if the calculated average of all collected HBPM measurements was ≥ 135/85 mmHg, the patient was considered to have HTN [16, 29] . Guidelines on making a HTN diagnosis using HBPM vary in the quantity and timing of measurements deemed necessary; in some it is recommended to average twelve or more BP measurements over at least seven days, while in others it is recommended to perform only three days of measurements [16, 30, 31] . However, a mean BP ≥ 135/85 mmHg is recommended uniformly, therefore this was the threshold used for our study definition of HTN. At the conclusion of the study, we provided primary care providers with the participant-completed HBPM log, so they could use the patient's measurements to make treatment decisions.
ED Attending Physician Survey
Emergency medicine board-certified attendings completed a brief in-person survey after their initial encounter with the enrolled participant. They were asked if they believed their patient would have HTN in follow-up (yes/no) after reviewing all the participants' BP measurements taken as part of routine ED care.
Data Analysis
We reported participant and visit characteristics using descriptive statistics. In-ED BpTRU measurements were categorized by HTN stage. We calculated the proportion of participants whose ED BpTRU measurement accurately predicted HTN using HBPM. Proportions of participants whose mean at-home BP met the ≥ 135/85 mmHg HTN threshold were calculated by in-ED HTN stage [32] , as follows: Pre-HTN was systolic BP 120-139 or diastolic BP 80-89 mmHg, Stage I HTN was systolic BP 140-159 or diastolic BP 90-99 mmHg, and Stage II HTN was systolic BP ≥ 160 mmHg or diastolic BP ≥ 100 mmHg [6, 33] . An α = 0.05 level of significance was used for comparisons. Data were recorded into the REDCap application and analyzed using SAS 9.4 (SAS Institute, Cary, NC, USA).
We also used ROC analysis to determine whether in-ED BP measurements (by both BpTRU and standard automated BP devices) could be use used to predict HTN. We used the same approach with ROC analysis to determine whether ED attending physicians could accurately predict whether their patient with elevated in-ED BP would have HTN after discharge. Since ED attending physicians were provided with the participants' in-ED BP values prior to the ED attending physician survey, we included the participant's initial BP in our prediction model. Therefore, we report what additional predictive value physician gestalt provides over the use of in-ED BPs alone to make a determination of HTN in follow-up. We calculated areas under the curve with Wald confidence intervals. We examined the sensitivity, specificity, positive predictive value and negative predictive value for ED attending physician prediction along with 95% confidence intervals. Additionally, we examined factors associated with a HTN diagnosis at two weeks using logistic regression.
Results
Of the 452 patients approached with elevated triage BP, 189 did not meet eligibility criteria and 112 declined enrollment. The remaining 151 patients were enrolled in the study, but eleven were excluded due to hospital admission, three withdrew, and one was started on antihypertensive medication in the ED. Of 136 participants, 93 (68%) returned the HBPM device and had at least four valid home BP measurements (Fig. 1) . Participants obtained a mean of 29 measurement using the HBPM (SD: 17, range 4-59).
Patient and Visit Characteristics
Among the 93 participants, the median age was 40 yearsold (IQR 34-48); 55% were female, 19% were black, 58% were white, and 9% did not have health insurance. Sixty-nine percent of participants had a family history of HTN, and 60% presented to the ED for a medical problem while 36% had an injury. At study enrollment, more than half of the participants had at least one BP reading obtained within the past month (Table 1) . Participants who were not included in the analysis (n = 58), did not differ significantly from included participants in terms of demographics, health history, healthcare access, and visit characteristics with some exceptions: females were more likely to be included and included participants were more likely to be insured. 
How Accurate is ED-Measured BP in Predicting HTN After Discharge?
Among the 39 participants who's in-ED BP was in the pre-HTN range, 31% (95% CI 52-83%) had HTN after discharge. Of the 38 subjects with in-ED BP in the stage I range, 50% (95% CI 33-67%) had HTN after discharge. Of the sixteen participants with in-ED BPs in the stage II range, 75% (95% CI 48-93%) had HTN following ED discharge (Table 2 ).
How Accurate is Physician Gestalt in Predicting HTN After Discharge?
Fifty-eight percent of participants whose ED attending physician predicted they would meet criteria for HTN, met the study definition after discharge ( Table 3 ). The sensitivity of physician gestalt was 54% (95% CI 37-71%). The specificity was better at 66% (95% CI 49-80%). The positive predictive value was 58% (95% CI: 45% -70%) and negative predictive value was 63% (95% CI 53-72%) ( Table 4) .
Comparison of Methods to Predict HTN After Discharge
Using in-ED BpTRU measurements, HTN in follow-up could be predicted accurately in 71% (95% CI 60-81%) of participants. The mean in-ED BP value, recorded by automated BP devices during the ED visit as part of routine ED care, as well as the method using only triage BP had similar accuracy: 70% (95% CI 59-81%) and 68% (90% CI 57-79%), respectively (Table 5 ). In comparison, ED attending physician prediction accuracy was lower.
Patient and Visit Factors Associated with a HTN Diagnosis at 2 Weeks
We examined factors that were associated with HTN diagnosis at two weeks including highest education obtained, insurance type, last time BP was measured, reason for ED visit, family history of HTN, smoking, alcohol use, pain during visit, and anxiety during visit. After controlling for BP (using BpTRU measurements), the only factor that was significantly associated with a HTN diagnosis using HBPM was insurance status. Specifically, compared to participants with private health insurance those with government-based insurance had an aOR of 4.33 (95% CI 1.49-12.25) of being diagnosed with HTN. 
Discussion
In this pilot study, we found that ED-provided HBPM could be a valuable tool to detect HTN after discharge. While ED attending physician assessment was a poor predictor of postdischarge HTN, averaging in-ED BPs or using triage BP alone provided a fair estimate of HTN after discharge. ED clinicians could use this approach to advise patients on their risk of having HTN vs. spuriously elevated in-ED BP.
Prior Research on ED-Provided HBPM
Previous research on this topic is limited. No other studies have been published that evaluate ED-provided HBPM for detecting HTN or the ability of ED attending physicians to correctly classify patients as likely to have HTN in follow-up. A 2008 study by Tanabe et al. enrolled 189 ED patients without previously diagnosed HTN with two in-ED BP measurements ≥ 140/80 mmHg [7] . Participants were instructed to obtain their BP at home using HBPM and return the monitors after a seven-day period. Of the study cohort, 51% had elevated mean BP in follow-up. Increased pain and anxiety were not associated with a decrease in BP after the ED visit. Our study builds on this foundational research by including patients with pre-HTN range BP, which is now recognized as an important risk factor for cardiovascular disease and is the recommended screening threshold for HTN in EDs [34] [35] [36] [37] . Additionally, we extended the seven-day period of BP measurements used in the aforementioned study to address the concern that BPs may be spuriously elevated immediately after an ED visit. In this pilot study, patients with higher in-ED BPs were more likely to have HTN in follow-up. Consistent with prior research on ED patients with elevated BP, 75% of participants with in-ED BP ≥ 160/100 mmHg had persistently elevated BP in follow-up [33] . ED physicians, insurers, and other stakeholders should be aware that patients with higher in-ED BPs are an important group to target with more intense resources such as ED-provided HBPM. A population-based strategy that includes ED screening and management is necessary given the prevalence and cardiovascular morbidity that results from undiagnosed HTN.
Potential Benefits of HBPM for ED Patients
This pilot study demonstrates that HBPM is a viable option for patients with elevated BP when follow-up is not immediately available. While all patients with an elevated in-ED BP and no history of HTN should be referred for further HTN testing [9] , many might experience a long latency period before they can be reevaluated. In a recent study, ED patients without an established primary care provider were able to secure an appointment only one third of the time for HTN [24] . Even patients with established primary care providers have difficulty obtaining urgent follow-up after leaving the hospital [24, 38] . HBPM allows patients to collect BP data on their own while awaiting primary care visits. Primary care providers can use this data to make an HTN diagnosis, start antihypertensive medication, and determine which patients need to be prioritized for follow-up care.
HPBM can promote patient engagement and can be combined with visits to HTN clinics, mHealth BP self-management systems [15, 39] , and pharmacist-led BP monitoring and medication adjustment programs [40] . HTN-related ED visits are increasing [2] , which may indicate that there is a greater need for patient self-efficacy in monitoring and managing HTN. Wearable monitoring devices are becoming more prevalent and patients may embrace HBPM as an option when other follow-up is not immediately available. HBPM is also endorsed by European guidelines as an alternative to office-based measurements, in patients with presumed white-coat HTN, those at high risk of masked HTN, and those with BP variability [41] .
Policy and Practice Implications
ED physicians at this large academic medical center had poor accuracy in predicting whether participants would have HTN in follow-up even after being provided a list of the patient's in-ED BPs. Lack of accuracy may be due to the widely-held physician belief that the pain and anxiety of acute conditions invalidates in-ED BPs or the perception that primary care providers are exclusively responsible for HTN diagnosis and management [42, 43] . Our results indicate that ED clinicians should not rely on The cost of HBPM may be prohibitive for patients. However, integrated health care systems and EDs that have quality incentives or alternative payment models in place, could make HBPM available to their ED patients with elevated BP. The cost of validated HBPM devices range from USD $40 to $60 and prior studies show that HBPM can improve outcomes for patients with HTN [22, 23] . Office visits can be avoided for patients with controlled HTN or those with BPs that average < 135/85 mmHg at home. Therefore, ED-provided HBPM could be a cost-effective approach to HTN diagnosis and management even if only two thirds of patients comply with HBPM protocols.
Limitations
Although we aimed to recruit patients with a wide range of in-ED elevated BPs, our final sample included a greater percentage of participants with pre-HTN or stage I range BPs. Including admitted patients in our study would have allowed us to recruit more patients with stage II range in-ED BPs. However, this strategy would have also increased our likelihood of including patients with hypertensive emergencies rather than our target group of patients with undiagnosed asymptomatic HTN.
Our definition of HTN using HBPM might vary from other studies and we could have classified patients as having HTN, who would not be diagnosed with HTN by their primary care providers. There is no universally accepted definition of HTN using HBPM [16, 45, 46] . Additionally, surveys of primary care providers and specialists reveal that there is practice variability among clinicians in the recommended frequency and timing of HBPM measurements [47, 48] . However, we believe misclassification of HTN using our protocol is minimal, as our study participants obtained a mean of 29 HBPM measurements during the study period. Further research on the ideal frequency and timing of HBPM measurements after an ED visit is necessary.
Conclusions
In this study, HBPM after ED discharge was valuable for detecting patients with HTN. However, interventions are needed to maximize device return and compliance with frequent HBPM measurements. ED-based HTN screening and HBPM may help reduce rates of untreated and undiagnosed HTN.
